XBI vs. QQQ
XBI (SPDR S&P Biotech ETF) and QQQ (Invesco QQQ ETF) are both exchange-traded funds - XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index, while QQQ is a Nasdaq-100 fund tracking the NASDAQ-100 Index. Both are passively managed. Over the past 10 years, XBI returned 9.55%/yr vs 21.79%/yr for QQQ. A 0.62 correlation means they provide meaningful diversification when combined. XBI charges 0.35%/yr vs 0.18%/yr for QQQ.
Performance
XBI vs. QQQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XBI achieves a 9.73% return, which is significantly lower than QQQ's 17.57% return. Over the past 10 years, XBI has underperformed QQQ with an annualized return of 9.55%, while QQQ has yielded a comparatively higher 21.79% annualized return.
XBI
- 1D
- 0.79%
- 1M
- -0.79%
- YTD
- 9.73%
- 6M
- 9.02%
- 1Y
- 60.62%
- 3Y*
- 14.23%
- 5Y*
- -0.20%
- 10Y*
- 9.55%
QQQ
- 1D
- 0.59%
- 1M
- 0.22%
- YTD
- 17.57%
- 6M
- 17.85%
- 1Y
- 37.55%
- 3Y*
- 26.43%
- 5Y*
- 16.85%
- 10Y*
- 21.79%
XBI vs. QQQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBI SPDR S&P Biotech ETF | 9.73% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
QQQ Invesco QQQ ETF | 17.57% | 20.77% | 25.58% | 54.86% | -32.58% | 27.42% | 48.62% | 38.96% | -0.13% | 32.66% |
Correlation
The correlation between XBI and QQQ is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.42 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.46 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.53 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.56 |
Correlation (All Time) Calculated using the full available price history since Feb 6, 2006 | 0.62 |
The correlation between XBI and QQQ shifts across timeframes, from 0.42 (1 year) to 0.62 (all time), reflecting how their relationship changes across market environments.
XBI vs. QQQ - Sectors Allocation Comparison
Sectors
XBI
QQQ
Healthcare
Financial Services
Basic Materials
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
XBI
QQQ
Financial Services
XBI
QQQ
Basic Materials
XBI
QQQ
Communication Services
XBI
-
QQQ
Consumer Cyclical
XBI
-
QQQ
Consumer Defensive
XBI
-
QQQ
Energy
XBI
-
QQQ
Industrials
XBI
-
QQQ
Real Estate
XBI
-
QQQ
Technology
XBI
-
QQQ
Utilities
XBI
-
QQQ
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBI vs. QQQ — Risk / Return Rank
XBI
QQQ
XBI vs. QQQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XBI | QQQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.19 | ||
| Sortino ratioReturn per unit of downside risk | +0.38 | ||
| Omega ratioGain probability vs. loss probability | 1.37 | 1.37 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 6.12 | 3.01 | +3.11 |
| Martin ratioReturn relative to average drawdown | 18.07 | 11.22 | +6.85 |
Loading charts...
Drawdowns
XBI vs. QQQ - Drawdown Comparison
The maximum XBI drawdown since its inception was -63.89%, smaller than the maximum QQQ drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for XBI and QQQ.
Loading charts...
Drawdown Indicators
| XBI | QQQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.89% | -82.97% | +19.08% |
Max Drawdown (1Y)Largest decline over 1 year | -9.72% | -11.96% | +2.24% |
Max Drawdown (3Y)Largest decline over 3 years | -32.99% | -22.77% | -10.22% |
Max Drawdown (5Y)Largest decline over 5 years | -54.71% | -35.12% | -19.59% |
Max Drawdown (10Y)Largest decline over 10 years | -63.89% | -35.12% | -28.77% |
Current DrawdownCurrent decline from peak | -22.67% | -3.33% | -19.34% |
Average DrawdownAverage peak-to-trough decline | -20.93% | -32.75% | +11.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.30% | 3.20% | +0.10% |
Volatility
XBI vs. QQQ - Volatility Comparison
SPDR S&P Biotech ETF (XBI) has a higher volatility of 10.39% compared to Invesco QQQ ETF (QQQ) at 7.56%. This indicates that XBI's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XBI | QQQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.39% | 7.56% | +2.83% |
Volatility (6M)Calculated over the trailing 6-month period | 20.76% | 13.81% | +6.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.09% | 17.19% | +8.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.21% | 22.55% | +9.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.01% | 22.38% | +9.63% |
XBI vs. QQQ - Expense Ratio Comparison
XBI has a 0.35% expense ratio, which is higher than QQQ's 0.18% expense ratio.
Dividends
XBI vs. QQQ - Dividend Comparison
XBI's dividend yield for the trailing twelve months is around 0.33%, less than QQQ's 0.39% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
QQQ Invesco QQQ ETF | 0.39% | 0.45% | 0.56% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% |
XBI SPDR S&P Biotech ETF | 0.33% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
XBI and QQQ have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (10.39%) compared to QQQ (7.56%). In terms of maximum drawdown, XBI dropped -63.89% vs QQQ's -82.97%.
On 10-year performance, QQQ leads with 21.79% vs 9.55% for XBI. On fees, QQQ is cheaper at 0.18% per year. On volatility, QQQ has been the lower-risk option at 7.56%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, QQQ has performed better with a 21.79% return vs 9.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
QQQ is cheaper with a 0.18% expense ratio, compared with 0.35% for XBI.
QQQ has the higher dividend yield at 0.39%, compared with 0.33% for XBI.
XBI is categorized as Health & Biotech Equities, while QQQ is Nasdaq-100. XBI tracks S&P Biotechnology Select Industry Index, while QQQ tracks NASDAQ-100 Index. They also come from different issuers: State Street and Invesco. Their fees differ too: 0.35% for XBI and 0.18% for QQQ.
XBI currently has the higher Sharpe Ratio (2.28 vs 2.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XBI and QQQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer